当前位置：药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目收费,不能显示细节,电话13136136841)
药品名称： 商品名称： 药品NDC： 报告期内： -格式:2020-5-3
NDC包装id： 市场分类： 活性成分： 持证企业：
 美国NDC复合药物数据库文件1279条(本栏目收费,不能显示细节,电话13136136841)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
Norepinephrine 8mg added to NS
HUMAN COMPOUNDED DRUG
71285-8096
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
NOREPINEPHRINE BITARTRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
8 mg/250 mL
71285-8096-1
Induction 4 to1 High K (50 mEq) In Plasmalyte A, ph 7.4 with Tromethamine 500ml Bag
HUMAN COMPOUNDED DRUG
71285-0111
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
MANNITOL; MAGNESIUM SULFATE HEPTAHYDRATE; SODIUM CHLORIDE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE; TROMETHAMINE; DEXTROSE MONOHYDRATE; SODIUM ACETATE; SODIUM GLUCONATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
3.6 g/500 mL; 20.3 meq/500 mL; 1.9725 g/500 mL; 3.86375 g/500 mL; .1125 g/500 mL; 2.268 g/500 mL; 6.51 g/500 mL; 1.38 g/500 mL; 1.8825 g/500 mL
71285-0111-1
Trophamine 3% / Dextrose 5% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag
HUMAN COMPOUNDED DRUG
72196-0419
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
GLUTAMIC ACID; LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE; CALCIUM GLUCONATE MONOHYDRATE; HEPARIN SODIUM
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.375 g/250 mL; .9 g/250 mL; .285 g/250 mL; .033 g/250 mL; .18 g/250 mL; .315 g/250 mL; .018 g/250 mL; .36 g/250 mL; .9 g/250 mL; .01875 g/250 mL; 12.5 g/250 mL; 1.05 g/250 mL; .255 g/250 mL; .51 g/250 mL; .24 g/250 mL; .615 g/250 mL; .405 g/250 mL; .27 g/250 mL; .36 g/250 mL; .15 g/250 mL; .585 g/250 mL; 3.75 meq/250 mL; 125 U/250 mL
72196-0419-1
Oxytocin 20units added to D5LR
HUMAN COMPOUNDED DRUG
71285-6031
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
OXYTOCIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 [USP'U]/1000 mL
71285-6031-1
Oxytocin 30units added to D5LR
HUMAN COMPOUNDED DRUG
71285-6032
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
OXYTOCIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
30 [USP'U]/500 mL
71285-6032-1
Oxytocin 10units added to LR
HUMAN COMPOUNDED DRUG
71285-6036
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
OXYTOCIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 [USP'U]/500 mL
71285-6036-1
Oxytocin 15units added to LR
HUMAN COMPOUNDED DRUG
71285-6037
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
OXYTOCIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
15 [USP'U]/250 mL
71285-6037-1
Oxytocin 20units added to LR
HUMAN COMPOUNDED DRUG
71285-6038
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
OXYTOCIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 [USP'U]/1000 mL
71285-6038-1
Oxytocin 30units added to LR
HUMAN COMPOUNDED DRUG
71285-6039
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
OXYTOCIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
30 [USP'U]/500 mL
71285-6039-1
Oxytocin 15units added to NS
HUMAN COMPOUNDED DRUG
71285-6042
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
OXYTOCIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
15 [USP'U]/250 mL
71285-6042-1
Fentanyl Citrate 50mcg/ml
HUMAN COMPOUNDED DRUG
71286-2003
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
FENTANYL CITRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 ug/1 mL
71286-2003-4
Fentanyl Citrate 50mcg/ml
HUMAN COMPOUNDED DRUG
71286-2003
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
FENTANYL CITRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 ug/1 mL
71286-2003-1
Fentanyl Citrate 50mcg/ml
HUMAN COMPOUNDED DRUG
71286-2003
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
FENTANYL CITRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 ug/1 mL
71286-2003-5
Phenylephrine 100 mcg/mL in 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
70004-810
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.1 mg/1 mL
70004-810-12
Phenylephrine 100 mcg/mL in 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
70004-810
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.1 mg/1 mL
70004-810-22
Labetalol 5 mg/mL
HUMAN COMPOUNDED DRUG
70004-700
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
LABETALOL HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 mg/1 mL
70004-700-28
Fentanyl 10 mcg/mL in 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
70004-229
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
FENTANYL CITRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.01 mg/1 mL
70004-229-40
Neostigmine Methylsulfate
HUMAN COMPOUNDED DRUG
71449-103
Denver Solutions, LLC dba Leiters Health
2021/2/1 0:00:00
NEOSTIGMINE METHYLSULFATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
71449-103-11
Moxifloxacin Hydrochloride
HUMAN COMPOUNDED DRUG
71449-096
Denver Solutions, LLC dba Leiters Health
2021/2/1 0:00:00
MOXIFLOXACIN HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
71449-096-42
Tropicamide, Phenylephrine Hydrochloride
HUMAN COMPOUNDED DRUG
71449-098
Denver Solutions, LLC dba Leiters Health
2021/2/1 0:00:00
TROPICAMIDE; PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 mL; 25 mg/1 mL
71449-098-47
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3